LONDON UK (Agencies) – The covid-19 vaccine being developed by Oxford University and AstraZeneca will be sold “at cost” worldwide. This statement was said by the director of the British pharmaceutical laboratory, which hopes to deliver it “before the end of the year”. They estimate that it could cost 2.5 euros per unit (about 65 Mexican pesos).
“Our goal is to supply the vaccine to everyone, we have a goal that is also to do so without benefit, that is, we will deliver the vaccine at cost price worldwide,” Pascal Soriot, AstraZeneca’s CEO, told RTL. “At cost price it will be about 2.5 euros per unit,” he added about the vaccine that has shown positive effects against the new coronavirus SARS CoV2.
The US group Johnson & Johnson hopes to do the same, while Pfizer, Merck and Moderna confirmed that they will not sell their covid-19 vaccines at cost price, during a hearing at the US Congress. “We will not sell at cost” said Moderna president Stephen Hoge in response to a question from a congressman. The biotechnology company has developed one of the most advanced experimental vaccines, with phase 3 trials starting next week on 30,000 volunteers.
The company received $483 million in public money from the United States to fund research and development, but without a supply contract for the country, Hoge said.
The first clinical trials of AstraZeneca’s vaccine produced a significant immune response and proved safe for patients. Its efficacy must be established in a Phase 3 trial, with much larger numbers of participants, before it can be considered for commercialisation. “Our hope is to have results in the fall (for this Phase 3 study), so we think we will be able to provide the covid-19 vaccine by the end of the year at the latest,” Soriot said. “We are working in concert with the regulators, exchanging data on a daily basis so that the evaluation can be done quickly. We manufacture at the same time as we do clinical trials, which saves time,” he said.
The group began producing vaccines “in many regions” so that they are “ready to be used if clinical results are positive,” according to AstraZeneca’s director.
more recommended stories
Influenza season ends with six deaths in Yucatan
The 2021-2022 seasonal influenza season concluded.
Bull escapes and injures a seven-year-old boy in Espita Yucatán
On Friday May 20th, a bull.
Due to excessively expensive municipal operating licenses, tourists and locals were left without beer in Progreso, Yucatan
After all the Six beer agencies.
Covid-19 in Yucatan: ”The pandemic is not over yet”, expert warns about summer vacations
The gradual rebound in Covid-19 infections.
IMSS Yucatan makes a public recognition to Nursing Staff
The Mexican Institute of Social Security.
Xcaret postpones the 14th edition of the Sacred Maya Journey
The return of the traditional Sacred.
A woman is crushed to death when a tree falls on top of her car on the Mérida-Valladolid highway
A strange accident happened on Thursday,.
With these local flowers, you help prevent the loss of bees in Yucatan
Every May 20, World Bee Day.
US government officials talk about UFOs publicly for the first time in 50 years
Two senior U.S. defense intelligence officials.
The US Embassy to invest 30 million USD in the “South of Mexico Generating Employment and Sustainability” program
In alliance with seven governments from.